Song, Jinlin <br/><br/>
Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia.  [electronic resource] 

 -  Advances in therapy  04 2019 
 - 950-961 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-019-0873-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Bispecific--administration & dosage<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Bone Marrow Examination--methods<br/>Comparative Effectiveness Research<br/>Female<br/>Humans<br/>Inotuzumab Ozogamicin--administration & dosage<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Remission Induction--methods<br/>Secondary Prevention--methods<br/>Survival Rate